Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25K Sell
1,425
-105
-7% -$2.25K 0.02% 1027
2025
Q4
$39K Sell
1,530
-1,079
-41% -$24.8K 0.02% 1005
2025
Q3
$56K Buy
2,609
+1,624
+165% +$36.9K 0.03% 856
2025
Q2
$22K Sell
985
-121
-11% -$2.65K 0.01% 1224
2025
Q1
$25K Sell
1,106
-5,762
-84% -$124K 0.02% 1121
2024
Q4
$118K Buy
6,868
+2,814
+69% +$43.7K 0.07% 423
2024
Q3
$68K Buy
4,054
+592
+17% +$14.2K 0.04% 730
2024
Q2
$99K Buy
3,462
+2,923
+542% +$88K 0.06% 490
2024
Q1
$21K Buy
539
+282
+110% +$10.7K 0.01% 1204
2023
Q4
$10K Hold
257
0.01% 1581
2023
Q3
$9K Sell
257
-1
-0.4% -$38 0.01% 1495
2023
Q2
$10K Sell
258
-2
-0.8% -$72 0.01% 1447
2023
Q1
$8K Hold
260
0.01% 1430
2022
Q4
$8K Buy
+260
New +$9.4K 0.01% 1429
2022
Q3
Sell
-262
Closed -$8K 2431
2022
Q2
$8K Sell
262
-93
-26% -$3.33K 0.01% 1292
2022
Q1
$18K Buy
355
+55
+18% +$2.35K 0.01% 1097
2021
Q4
$15K Buy
+300
New +$16.8K 0.02% 917

Other funds holding PGNY

Covestor's PGNY Position: Q1 2026 in Review

Covestor reduced its Progyny (PGNY) stake by 6.9% in Q1 2026, selling an estimated $2.25K and leaving 1,425 shares worth $25K. The position accounts for 0.02% of the portfolio, ranked #1027.

Covestor first reported a position in PGNY in Q4 2021 and has held it in 17 quarters since. The position peaked at $118K in Q4 2024. 292 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • Covestor held 1,425 shares of Progyny worth $25K as of Q1 2026.
  • Covestor sold 105 Progyny shares in Q1 2026, an estimated $2.25K.
  • Progyny made up 0.02% of Covestor's portfolio in Q1 2026, its #1027 holding.
  • Covestor first reported a position in Progyny in Q4 2021 and has held it in 17 quarters since.
  • Covestor's Progyny position peaked at $118K in Q4 2024.
  • 292 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.